¿Existe la misma exigencia en la obtención del doctorado (PhD) en todos los departamentos de cirugía de las universidades españolas? / Is there the same requirement to obtain the PhD degree in all the departments of surgery of the Spanish universities?

Introducción El doctorado es el tercer ciclo de estudios universitarios oficiales, que mediante la defensa de la tesis doctoral conduce a la adquisición del título de doctor. El Real Decreto 99/2011 regula los programas de doctorado, con un amplio margen en su exigencia. El objetivo de este estudio ha sido conocer si existe discrepancia de los programas de doctorado entre los departamentos de cirugía de las universidades públicas españolas y establecer una escala de calidad. Métodos Estudio observacional transversal mediante una encuesta enviada por vía telemática a los profesores de los departamentos de cirugía. Resultados Se ha consultado a los 35 departamentos de cirugía, obteniendo respuesta de 29 de ellos (82,9%). La variación en la exigencia se ha observado especialmente en la calidad del proyecto de investigación, sin existir normativa en 25 (86,2%) de los programas. En cuanto a la presentación de la tesis doctoral en forma de compendio de artículos, se exige que sean originales en 15 (51,7%). En 14 (48,4%) de los programas la posición como autor del doctorando debe ser de autor preferente al menos en 2 artículos. En 14 departamentos (48,4%) no existe normativa respecto a la posición por cuartiles de los artículos. Al puntuar los distintos programas según su exigencia, la variabilidad es elevada, oscilando entre 2 y 19 puntos. La financiación para el desarrollo del doctorado fue mínima. Conclusiones Existe una amplia variabilidad en la exigencia de los programas de doctorado. Sería aconsejable definir unos niveles mínimos de exigencia para salvaguardar aquellas tesis de mayor nivel (AU)

Introduction The doctorate is the third cycle of official university studies, which, through the defense of the doctoral thesis leads to the acquisition of the title of doctor or PhD from the Anglo-Saxon countries. Royal Decree law 99/2011 regulates doctoral programs, with a wide margin on quality requirements. The objective of this study is to find out if there is this variation in the requirements of the doctorate programs of the different departments of surgery of the Spanish public universities and to establish a quality scale. Methods Cross-sectional observational study from 2/22/2021 to 3/3/2021, through a survey sent electronically to the professors of the departments of surgery. Results Thirty-five departments of surgery were consulted, obtaining a response in 29 of them (82.9%). The observed variation regarding requirements has been basically in the quality of the research project, in fact in 25 (86.2%) there are no regulations on this. When it is presented in the form of a compendium of articles, these are required to be original in 15 (51.7%). Regarding the position as author, the doctoral student must be the preferred author, at least in 2 articles in 14 (48.4%) of the programs. In 14 departments (48.4%) there are no regulations on the position of the articles and quartiles of journals. When scoring the different programs according to their requirements, the variability is high, ranging between 2 and 19 points. Funding for the development of the doctorate is meager. Conclusions There is a wide variability in the requirement of doctoral programs. Homogeneous levels of demand must be defined to promote and protect higher-level doctorates (AU)

Marcadores urinarios en la vigilancia del tumor vesical no músculo infiltrante. Revisión de la literatura / Urinary markers in the surveillance of non-muscle invasive bladder cancer. A literature review

Contexto: La vigilancia del tumor vesical no músculo infiltrante (TVNMI) se realiza habitualmente mediante cistoscopia y citologías urinarias seriadas. Hoy, no se utiliza ningún marcador urinario, suficientemente eficaz, para reducir la morbilidad y coste de este seguimiento. Objetivo: Describir el rendimiento de los marcadores urinarios en la vigilancia del TVNMI. Adquisición de la evidencia: el 1 de agosto de 2018 se realizó búsqueda bibliográfica en Pubmed, Embase y librería Cochrane, acotada a los últimos 10 años, con los términos: bladder cancer, recurrence, detection y urine marker. Se obtuvieron 973 registros y siguiendo las recomendaciones PRISMA se seleccionaron 27 publicaciones. Síntesis de la evidencia: Los valores predictivos negativos de varios ensayos permitirían reducir el número de cistoscopias en la vigilancia del TVNMI. Seis ensayos de factores de transcripción tuvieron un valor predictivo negativo superior al 90% y uno de ellos se puede realizar en el punto de control. Seis ensayos de factores de transcripción describen diagnóstico anticipado entre el 68% y 83% de sus «falsos positivos». Dos ensayos de factores de transcripción y uno de proteínas demuestran reducir entre el 23% y el 35% de las cistoscopias de vigilancia. Los ensayos celulares se restringen a pruebas reflejo ante citologías urinarias dudosas. Conclusión: Existen pocas publicaciones que permitan analizar la mejoría del protocolo de vigilancia del TVNMI. Los ensayos de factores de transcripción tienen la mejor precisión diagnóstica y algunos permiten diagnóstico anticipado. Hoy en día no hay análisis que comparen entre protocolos alternativos de vigilancia y el convencional

Background: The surveillance of non-muscle-invasive bladder cancer (NMIBC) is usually performed by cystoscopy and cytology. Until today, no effective urinary biomarker has been used to reduce the morbidity and cost associated with these procedures. Objective: To describe the performance of urinary biomarkers in the surveillance of NMIBC. Evidence acquisition: on August 1, 2018, a bibliographic search was carried out in Pubmed, Embase and Cochrane Library, limited to the last 10 years, with the terms: bladder cancer, recurrence, detection and urine marker.973 registers were obtained, and 27 publications were selected following the PRISMA recommendations. Evidence synthesis: The negative predictive values (NPV) of several assays could reduce the number of cystoscopies in NMIBC surveillance. Six transcription-factor trials had an NPV rate greater than 90%, and one of them can be performed at the control point. Six transcription-factors evaluations describe anticipated diagnosis between 68% and 83% of their "false positives". Two transcription factors and one protein assays proved reduction between 23% and 35% of surveillance cystoscopies. Nowadays, cell-based assays are restricted to reflex test after doubtful cytologies. Conclusion: There are few studies analysing the improvement of the NMIBC surveillance protocols. Several transcription factor assays are more precise and allow anticipatory diagnosis. Currently, there are no comparative studies between alternative surveillance protocols and classic ones

Análisis del escenario microscópico de una biopsia prostática negativa como predictor del riesgo de cáncer de próstata. Una revisión sistemática / In Search for risk predictors at the microscopic scenario of a negative biopsy. A systematic review

Introducción: Las biopsias prostáticas (BP) de repetición, ante la persistencia de la sospecha de cáncer de próstata (CP), son frecuentes y su rendimiento bajo. En el contexto de una BP negativa existe un escenario microscópico (EM), que definimos como el conjunto de lesiones no neoplásicas identificable. La existencia de algunas de estas lesiones incrementa el riesgo de detección de CP en BP sucesivas, mientras que otras parecen tener un efecto protector. El objetivo de esta revisión sistemática es identificar el conjunto de lesiones que puede formar parte del EM de una BP negativa y analizar la evidencia actual de su asociación con el riesgo de detección de CP en BP sucesivas. Adquisición de la evidencia: Dos revisores independientes realizaron una búsqueda bibliográfica en Medline, Embase y Central Cochrane, con los términos de búsqueda: small acinar proliferation or ASAP or prostatic intraepithelial neoplasia or HGPIN or adjacent small atypical glands or pinatyp or atrophy or proliferative inflammatory atrophy or pia or prostatic inflammation or prostatitis and prostate cancer. Se identificaron 1.015 referencias y siguiendo los principios de la declaración PRISMA y de selección PICO, se identificaron 57 artículos originales válidos para esta revisión. Síntesis de la evidencia: La proliferación acinar atípica de célula pequeña se asocia a una tasa de detección de CP en BP sucesivas que oscila entre el 32 y 48%. La neoplasia intraepitelial prostática de alto grado (HGPIN) se asocia a CP entre el 13 y 42%, siendo su multifocalidad la que define el incremento en el riesgo de detección. La atrofia prostática, la atrofia proliferativa inflamatoria y la infamación prostática parecen tener un efecto protector sobre la detección de CP en BP sucesivas. Por otra parte, el riesgo de detección de CP en varones con HGPIN multifocal se reduce significativamente si coexiste atrofia proliferativa inflamatoria. Conclusiones: El EM de una BP negativa puede estar compuesto por las lesiones de proliferación acinar atípica de célula pequeña, HGPIN, atrofia prostática, atrofia proliferativa inflamatoria e infamación prostática ya que todas parecen estar asociadas al riesgo de detección de CP en BP sucesivas. Esta revisión nos permite generar la hipótesis de que el EM de una BP negativa puede ser de utilidad en la decisión indicar BP de repetición

Introduction: In cases of persistent suspicion of prostate cancer (PC), repeat prostate biopsies (PB) are frequently performed in spite of their low yield. In the context of a negative PB, there is a microscopic scenario (MS), which we define as the group of recognizable non-neoplastic lesions. While some of these lesions seem to have a protective effect, the existence of others increases the risk of PC detection in posterior PB. The objective of this systematic review is to identify the lesions that may belong to the MS of a negative PB and analyse the current evidence of their association with the risk of detecting PC in subsequent PBs. Evidence acquisition: Two independent reviewers conducted a literature search on Medline, Embase and Central Cochrane with the following search terms: small acinar proliferation, ASAP, prostatic intraepithelial neoplasia, HGPIN, adjacent small atypical glands, pinatyp, atrophy, proliferative inflammatory atrophy, pia, prostatic inflammation, prostatitis and prostate cancer. 1,015 references were first identified, and 57 original articles were included in the study, following the PRISMA declaration and the PICO selection principles. Evidence synthesis: Atypical small acinar proliferation is associated with PC detection in repeat PB with rates ranging between 32 and 48%. High-grade prostatic intraepithelial neoplasia (HGPIN) is related to PC in 13 to 42% of cases. Studies show that HGPIN, when multifocal, is a significant independent risk factor for PC. Prostatic atrophy, inflammatory proliferative atrophy and prostatic inflammation seem to act as protective factors on the detection of PC in repeat PB. On the other hand, the risk of PC detection reduces significantly in male patients with multifocal HGPIN and coexistent PIA. Conclusions: The MS of a negative PB may include atypical small acinar proliferation, HGPIN, prostatic atrophy, inflammatory proliferative atrophy and prostatic inflammation lesions, since they all seem to be associated with the risk of PC detection in repeat PB. This review has led us to create the hypothesis that the MS of a negative PB might be a valuable and useful tool when considering repeat PB

In Search for risk predictors at the microscopic scenario of a negative biopsy. A systematic review. / Análisis del escenario microscópico de una biopsia prostática negativa como predictor del riesgo de cáncer de próstata. Una revisión sistemática.

INTRODUCTION: In cases of persistent suspicion of prostate cancer (PC), repeat prostate biopsies (PB) are frequently performed in spite of their low yield. In the context of a negative PB, there is a microscopic scenario (MS), which we define as the group of recognizable non-neoplastic lesions. While some of these lesions seem to have a protective effect, the existence of others increases the risk of PC detection in posterior PB. The objective of this systematic review is to identify the lesions that may belong to the MS of a negative PB and analyse the current evidence of their association with the risk of detecting PC in subsequent PBs. EVIDENCE ACQUISITION: Two independent reviewers conducted a literature search on Medline, Embase and Central Cochrane with the following search terms: small acinar proliferation, ASAP, prostatic intraepithelial neoplasia, HGPIN, adjacent small atypical glands, pinatyp, atrophy, proliferative inflammatory atrophy, pia, prostatic inflammation, prostatitis and prostate cancer. 1,015 references were first identified, and 57 original articles were included in the study, following the PRISMA declaration and the PICO selection principles. EVIDENCE SYNTHESIS: Atypical small acinar proliferation is associated with PC detection in repeat PB with rates ranging between 32 and 48%. High-grade prostatic intraepithelial neoplasia (HGPIN) is related to PC in 13 to 42% of cases. Studies show that HGPIN, when multifocal, is a significant independent risk factor for PC. Prostatic atrophy, inflammatory proliferative atrophy and prostatic inflammation seem to act as protective factors on the detection of PC in repeat PB. On the other hand, the risk of PC detection reduces significantly in male patients with multifocal HGPIN and coexistent PIA. CONCLUSIONS: The MS of a negative PB may include atypical small acinar proliferation, HGPIN, prostatic atrophy, inflammatory proliferative atrophy and prostatic inflammation lesions, since they all seem to be associated with the risk of PC detection in repeat PB. This review has led us to create the hypothesis that the MS of a negative PB might be a valuable and useful tool when considering repeat PB.

Urinary markers in the surveillance of non-muscle invasive bladder cancer. A literature review. / Marcadores urinarios en la vigilancia del tumor vesical no músculo infiltrante. Revisión de la literatura.

BACKGROUND: The surveillance of non-muscle-invasive bladder cancer (NMIBC) is usually performed by cystoscopy and cytology. Until today, no effective urinary biomarker has been used to reduce the morbidity and cost associated with these procedures. OBJECTIVE: To describe the performance of urinary biomarkers in the surveillance of NMIBC. EVIDENCE ACQUISITION: on August 1, 2018, a bibliographic search was carried out in Pubmed, Embase and Cochrane Library, limited to the last 10 years, with the terms: bladder cancer, recurrence, detection and urine marker.973 registers were obtained, and 27 publications were selected following the PRISMA recommendations. EVIDENCE SYNTHESIS: The negative predictive values (NPV) of several assays could reduce the number of cystoscopies in NMIBC surveillance. Six transcription-factor trials had an NPV rate greater than 90%, and one of them can be performed at the control point. Six transcription-factors evaluations describe anticipated diagnosis between 68% and 83% of their "false positives". Two transcription factors and one protein assays proved reduction between 23% and 35% of surveillance cystoscopies. Nowadays, cell-based assays are restricted to reflex test after doubtful cytologies. CONCLUSION: There are few studies analysing the improvement of the NMIBC surveillance protocols. Several transcription factor assays are more precise and allow anticipatory diagnosis. Currently, there are no comparative studies between alternative surveillance protocols and classic ones.

Revisión sistemática de los métodos predictores de la funcionalidad del trasplante renal / Systematic review of kidney transplantation functional predictors

Contexto: El trasplante renal de donantes con criterios expandidos ha aumentado el pool de riñones a costa de un riesgo superior de disfunción del injerto a corto y/o largo plazo. La cuestión principal reside en determinar qué riñones ofrecerán una función y supervivencia aceptables comparado con el riesgo que supone la cirugía y la posterior inmunosupresión. Objetivo: El objetivo de nuestro artículo es revisar la evidencia actual sobre las herramientas para predecir la funcionalidad del trasplante renal de donantes de cadáver con criterios expandidos y determinar la validez para su uso en la práctica habitual. Adquisición de evidencia: Hemos realizado una revisión sistemática de la literatura según los criterios PRISMA, a través de Medline (http://www.ncbi.nlm.nih.gov), utilizando las palabras clave, aisladas o conjuntamente: cadaveric renal transplantation; kidney graft function appraisal; graft function predictors. Se seleccionaron series prospectivas y retrospectivas, así como artículos de revisión. Un total de 375 artículos fueron analizados, de los cuales 39 fueron finalmente seleccionados para revisión. Síntesis de evidencia: Entre los predictores de la funcionalidad se encuentran: los índices de riesgo del donante; el cálculo del peso funcional renal o la valoración de la masa nefrónica; la medición de las resistencias vasculares durante la perfusión en hipotermia; la medición de biomarcadores en la orina del donante y en el líquido de perfusión; la medición de parámetros funcionales y de reperfusión en normotermia y la medición de los parámetros morfológicos, micro y macroscópicos, del órgano diana. En este artículo presentamos un resumen explicativo de cada uno de estos parámetros, así como su evidencia más reciente al respeto. Discusión: Ningún parámetro de los revisados fue capaz de predecir por sí mismo, con fiabilidad, la función renal y la supervivencia del trasplante. Existe un importante vacío en cuanto a la valoración macroscópica del trasplante renal. Conclusiones: Es necesario continuar desarrollando los predictores de la funcionalidad renal para definir con precisión la distribución de cada uno de los riñones de los donantes que disponemos en la actualidad

Context: Kidney transplantation from donors with expanded criteria has increased the pool of kidneys at the cost of a higher risk of short and long-term graft dysfunction. The main issue lies in determining which kidneys will offer acceptable function and survival compared with the risk represented by surgery and subsequent immunosuppression. Objective: The objective of our article is to review the current evidence on the tools for predicting the functionality of kidney transplantation from cadaveric donors with expanded criteria and determining the validity for their use in standard practice. Acquisition of evidence: We conducted a systematic literature review according to the PRISM criteria, through Medline (http://www.ncbi.nlm.nih.gov) and using the keywords (in isolation or in conjunction) "cadaveric renal transplantation; kidney graft function appraisal, graft function predictors". We selected prospective and retrospective series and review articles. A total of 375 articles were analysed, 39 of which were ultimately selected for review. Summary of the evidence: The predictors of functionality include the following: The donor risk indices; the calculation of the renal functional weight or the assessment of the nephronic mass; the measurement of vascular resistances during perfusion in hypothermia; the measurement of the donor's biomarkers in urine and in the perfusion liquid; the measurement of functional and reperfusion parameters in normothermia; and the measurement of morphological parameters (microscopic and macroscopic) of the target organ. In this article, we present an explanatory summary of each of these parameters, as well as their most recent evidence on this issue. Discussion: None of the reviewed parameters in isolation could reliably predict renal function and graft survival. There is a significant void in terms of the macroscopic assessment of kidney transplantation. Conclusions: We need to continue developing predictors of renal functionality to accurately define the distribution of each currently available donor kidney

Systematic review of kidney transplantation functional predictors. / Revisión sistemática de los métodos predictores de la funcionalidad del trasplante renal.

CONTEXT: Kidney transplantation from donors with expanded criteria has increased the pool of kidneys at the cost of a higher risk of short and long-term graft dysfunction. The main issue lies in determining which kidneys will offer acceptable function and survival compared with the risk represented by surgery and subsequent immunosuppression. OBJECTIVE: The objective of our article is to review the current evidence on the tools for predicting the functionality of kidney transplantation from cadaveric donors with expanded criteria and determining the validity for their use in standard practice. ACQUISITION OF EVIDENCE: We conducted a systematic literature review according to the PRISM criteria, through Medline (http://www.ncbi.nlm.nih.gov) and using the keywords (in isolation or in conjunction) "cadaveric renal transplantation; kidney graft function appraisal, graft function predictors". We selected prospective and retrospective series and review articles. A total of 375 articles were analysed, 39 of which were ultimately selected for review. SUMMARY OF THE EVIDENCE: The predictors of functionality include the following: The donor risk indices; the calculation of the renal functional weight or the assessment of the nephronic mass; the measurement of vascular resistances during perfusion in hypothermia; the measurement of the donor's biomarkers in urine and in the perfusion liquid; the measurement of functional and reperfusion parameters in normothermia; and the measurement of morphological parameters (microscopic and macroscopic) of the target organ. In this article, we present an explanatory summary of each of these parameters, as well as their most recent evidence on this issue. DISCUSSION: None of the reviewed parameters in isolation could reliably predict renal function and graft survival. There is a significant void in terms of the macroscopic assessment of kidney transplantation. CONCLUSIONS: We need to continue developing predictors of renal functionality to accurately define the distribution of each currently available donor kidney.

Extensive emphysematous pyelonephritis in a renal allograft: case report and review of literature.

Emphysematous pyelonephritis (EPN) is an acute, severe necrotizing infection of the renal parenchyma and perirenal tissue, which results in the presence of gas within the renal parenchyma, collecting system, or perinephric tissue. EPN of renal allograft is rare, with only 23 cases reported in Western literature. Here, we report a patient treated successfully with surgery. We also review the literature, focusing on old and new suggested classification systems for EPN.

Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy.

The aim of this study was to evaluate bone mass changes after 1 year of four different types of pharmacological intervention. Ninety-seven prostate cancer patients treated with androgen deprivation therapy, and severe osteopenia or osteoporosis were retrospectively studied. Patients were divided in four groups. Group 1: 28 patients treated with denosumab, Group 2: 24 patients treated with alendronate, Group 3: 24 patients with no antiresorptive treatment and Group 4: 21 patients previously treated with alendronate and switched to denosumab. Dual X-ray absorptiometry was performed at baseline and after 1 year. Bone mass changes at the L2-L4 lumbar spine, femoral neck and total hip were evaluated. No differences were found at baseline. After 1 year, men receiving denosumab or alendronate (Group 1 and 2) showed a significant bone mass increase at the lumbar spine (+2.4 and +5.0 %, respectively), while no significant changes were observed in Group 3 and 4. At the femoral neck, Group 1 and 2 patients showed a significant bone mass increase (+3.7 and +3.6 %, respectively), while no significant changes were observed in Group 3 and 4. At the total hip, we observed a significant bone mass increase in Group 1 (+2.9 %) and a significant bone mass loss in Group 3 patients (-1.9 %). No significant changes were observed in Group 2 and 4. Denosumab increased significantly bone mass in all three dual X-ray absorptiometry standard sites, while alendronate did not at total hip. No benefit was observed in men previously treated with alendronate who switched to denosumab treatment.

[Priapism secondary to penis infiltration of bladder cancer]. / Priapismo secundario a infiltración peneana por contigüidad de carcinoma vesical infiltrante.

Metastasic priapism is a rare entity produced by tumor cell implantation or direct infiltration of corpora cavernousum of the penis. In up to 80% of cases the primary tumor has an urological origen like prostate or bladder cancers. Treatment depends on syntomatology and patient's prognosis. Generally, average survival in these patients is poor due to metastasic progression, among 1 to 1 and a half years. We present a case report of secondary priapism for direct invasion of the corpora cavernousum of the penis for bladder carcinoma.

Priapismo secundario a infiltración peneana por contigüidad de carcinoma vesical infiltrante / Priapism secondary to penis infiltration of bladder cancer

El priapismo de origen metastático es una entidad muy poco frecuente que se produce por implantación de células tumorales, o bien, por invasión directa por contigüidad de los cuerpos cavernosos. Hasta en un 80% de los casos el origen de los tumores primarios es genitourinario, principalmente por tumores prostáticos y vesicales. El tratamiento dependerá de la sintomatología que produzca y del pronóstico del paciente; pero generalmente, la supervivencia al año es muy pobre debido a que presentan una neoplasia en fase metastásica. Presentamos un caso de priapismo por invasión por contigüidad de los cuerpos cavernosos secundario a un carcinoma vesical (AU)

Metastasic priapism is a rare entity produced by tumor cell implantation or direct infiltration of corpora cavernousum of the penis. In up to 80% of cases the primary tumor has an urological origen like prostate or bladder cancers. Treatment depends on syntomatology and patient’s prognosis. Generally, average survival in these patients is poor due to metastasic progression, among 1 to 1 and a half years. We present a case report of secondary priapism for direct invasion of the corpora cavernousum of the penis for bladder carcinoma (AU)

[Adenomatoid tumour of epididymis: the most common tumour of the paratesticular structures]. / Tumor adenomatoide de epididimo: el tumor más frecuente de las estructuras paratesticulares.

INTRODUCTION: Paratesticular tumours are rare but generally benign neoplasms, usually treated by local excission. Adenomatoid tumours of epididymis are the most common of these tumours. OBJECTIVES: Analyze paratesticular tumours treated in our center and describe dyagnosis and treatment of adenomatoid tumours of epididymis. MATERIAL AND METHODS: We retrospectively review 8 patients with paratesticular tumours treated from July 1997 to July 2007. We analyze clinical presentation, dyagnostic suspicion given by image technique, treatment followed and final dyagnosis. RESULTS: Patients median age was 44.1 years (22-69), presenting most of them subacute scrotal tumour with median size by ultrasound of 2.8 cm (1.5-7). All of them were locally extirpated except one with suspicion of a malignant polyorchidism and another one with an apparently intratesticular lesion of great size. Just in two cases peroperatory biopsy was performed. Dyagnosis was in 4 cases adenomatoid tumour of epididymis, in two cases fibrous pseudotumour of epididymis, in one case leiomyoma of epididymis and in one case angiolipoma of spermatic cord. Just in one case diagnosed of adenomatoid tumour of epididymis ultrasound confirmed solid tumour suggesting the final dyagnosis. CONCLUSIONS: Adenomatoid tumors of epididymis are rare tumours which may present at any age. Ultrasound may help in dyagnosis, but its capacity to distinguish this lesions is low. Benignity of adenomatoid tumour of epididymis as well as most of the other paratesticular tumours should make local excission the treatment of choice and, when any doubt existed, peroperatory biopsy should be performed.

[Transitional cell carcinoma relapse in uretero-ileal conduit after radical cystectomy]. / Recidiva de carcinoma transicional en conducto uretero-ileal tras cistectomía radical.

Transitional cell carcinoma relapse in ileal conduit after radical cistectomy is a rare event, especially without upper urinary tract involvement. We describe a case of uretero-ileal transitional cell tumour five years after cistectomy for invasive urothelial tumour. Patient underwent endoscopic treatment with good results after 13 months of follow-up.

[Benign retroperitoneal schwannoma, laparoscopic ressection]. / Schwanoma retroperitoneal benigno, exéresis por laparoscopia.

Schwannomas are tumors rarely localized in the retroperitoneum, generally appear in craneal as well as periferic nerves. Seldom cases the diagnosis is preoperatively made just because imaging is very poor in this field. MRI is proven to be the diagnostic method. Radical surgical ressection is standarized treatment. We document a case of a benign retroperitoneal schwannoma where we explain the laparoscopic ressection of this kind of tumors for first time.

Tumor adenomatoide de epidídimo: el tumor más frecuente de las estructuras paratesticulares / Adenomatoid tumour of epididymis: them ost common tumour of the paratesticular structures

Introducción: Los tumores paratesticulares son neoplasias poco frecuentes aunque habitualmente benignas que suelen ser tributarias de extirpación local. Dentro de ellos se considera que los tumores adenomatoides de epidídimo constituyen el subgrupo más frecuente. Objetivos: Analizar los casos de tumores paratesticulares intervenidos en nuestro centro, así como el diagnóstico y tratamiento de los tumores adenomatoides de epidídimo. Material y métodos: Se revisan de forma retrospectiva 8 pacientes con tumores paratesticulares intervenidos entre julio de 1997 y julio 2007. Se analiza en cada caso la forma de presentación, la orientación diagnóstica que aportaba la prueba de imagen, el tratamiento indicado para cada paciente y el diagnóstico definitivo. Resultados: La edad media de los pacientes fue de 44,1 años (22-69), consultando la mayoría de ellos por tumoración escrotal de aparición subaguda que presentaban en la ecografía un tamaño medio de 2,8 cm (1,5-7). Se practicó la extirpación local en todos los casos a excepción de un paciente con sospecha de un teste accesorio malignizado y otro con una lesión aparentemente intratesticular de gran tamaño. Sólo en dos casos se practicó una biopsia peroperatoria. El diagnóstico fue en 4 casos de tumor adenomatoide de epidídimo, en dos casos de pseudotumor fibroso de epidídimo, en un caso de leiomioma de epidídimo y en otro de angiolipoma de cordón espermático. Sólo en un caso diagnosticado de tumor adenomatoide de epidídimo la ecografía informaba de tumoración sólida sugestiva del diagnóstico definitivo. Conclusiones: Los tumores adenomatoides de epidídimo son tumores poco frecuentes que se pueden diagnosticar a cualquier edad. La ecografía puede orientar el diagnóstico pero su capacidad para diferenciarlos es baja. La naturaleza habitualmente benigna tanto del tumor adenomatoide de epidídimo como del resto de tumores paratesticulares obligaría a practicar como primera opción la extirpación local de los mismos y, ante cualquier duda, debería practicarse una biopsia peroperatoria (AU)

Introduction: Paratesticular tumours are rare but generally benign neoplasms, usually treated by local excission. Adenomatoid tumours of epididymis are the most common of these tumours. Objectives: Analyze paratesticular tumours treated in our center and describe dyagnosis and treatment of adenomatoid tumours of epididymis. Material and Methods: We retrospectively review 8 patients with paratesticular tumours treated from July 1997 to July 2007. We analyze clinical presentation, dyagnostic suspicion given by image technique, treatment followed and final dyagnosis. Results: Patients median age was 44.1 years (22-69), presenting most of them subacute scrotal tumour with median size by ultrasound of 2.8 cm (1.5-7). All of them were locally extirpated except one with suspicion of a malignant polyorchidism and another one with an apparently intratesticular lesion of great size. Just in two cases peroperatory biopsy was performed. Dyagnosis was in 4 cases adenomatoid tumour of epididymis, in two cases fibrous pseudotumour of epididymis, in one case leiomyoma of epididymis and in one case angiolipoma of spermatic cord. Just in one case diagnosed of adenomatoid tumour of epididymis ultrasound confirmed solid tumour suggesting the final dyagnosis. Conclusions: Adenomatoid tumors of epididymis are rare tumours which may present at any age. Ultrasound may help in dyagnosis, but its capacity to distinguish this lesions is low. Benignity of adenomatoid tumour of epididymis as well as most of the other paratesticular tumours should make local excission the treatment of choice and, when any doubt existed, peroperatory biopsy should be performed (AU)

Recidiva de carcinoma transicional en conducto uretero-ileal tras cistectomía radical / Transitional cell carcinoma relapse in uretero-ileal conduit after radical cistectomy

La recidiva de un tumor urotelial en el conducto uretero-ileal tras una cistectomía es poco frecuente, especialmente sin afectación del tracto urinario superior. Presentamos un caso de afectación de la unión uretero-ileal por tumor urotelial en un paciente cistectomiazado desde hacía 5 años por un tumor vesical infiltrante, al cual se le somete a un tratamiento endoscópico de su lesión con buenos resultados a los 13meses de seguimiento (AU)

Transitional cell carcinoma relapse in ileal conduit after radical cistectomy is a rare event, especially without upper urinary tract involvement. We describe a case of uretero-ileal transitional cell tumour five years after cistectomy for invasive urothelial tumour. Patient underwent endoscopic treatment with good results after 13 months of follow-up (AU)

Cistectomía radical laparoscopica en los tumores vesicales clínicamente localizados. (T2) / Laparoscopic radical cystectomy in clinically localized (T2) bladder tumors

Objetivo: La cistectomía radical laparoscópica se ha desarrollado a partir de la expansión de la prostatectomía radical laparoscópica. Esta técnica permite un abordaje poco invasivo para el tratamiento de los tumores vesicales infiltrantes de la capa muscular con disminución del sangrado y una más rápida recuperación postoperatoria. Métodos: Entre septiembre de 2004 y enero de 2007 se han realizado 54 cistectomías radicales por vía laparoscópica, 48 en estadio T2 y de estas últimas 43 (90%) eran varones y 5 (10%) mujeres. La edad media fue de 64 años (27-88a). La linfadenectomía se practicó por acceso laparoscópico en todos los casos, obteniendo una media de 13 ganglios (4-24). La derivación urinaria se realizó por la incisión de extracción del espécimen en todos los casos menos uno que se realizó completamente intracorpóreo, siendo ureteroileostomía cutánea tipo Bricker en 30 casos (62%), neovejiga ortotópica tipo Padovana en 17 casos (35%) y ureterostomía cutánea en un caso (2%). Resultados: El tiempo quirúrgico medio de todo el procedimiento fue de 287 minutos (180-480), 270 minutos para los casos con derivación tipo Bricker y de 316 para los casos con una neovejiga. El índice de transfusión fue del 25%. El tiempo medio de íleo paralítico fue de 5 días (2-10d) con un tiempo medio de ingreso para los pacientes con Bricker de 13 días (6-34) y de 16 días (8-30) para las neovejigas. El control oncológico, con un seguimiento medio de 10,8 meses (0,4-30m), presenta una supervivencia cáncer específica del 90% con un tiempo medio de supervivencia estimado de 28 meses (IC 95% 26-30). La supervivencia media global ha sido del 79% con un tiempo de supervivencia de 26 meses (IC 95% 23-29). Conclusiones: La cistectomía radical laparoscópica es una técnica factible que ofrece ventajas. Permite una exéresis con un menor sangrado y un postoperatorio más llevadero. Estudios aleatorizados deberían demostrar estas ventajas para confirmar si puede llegar a ser la técnica de elección. La realización de la derivación urinaria por la laparotomía, obligada para la extracción de la pieza quirúrgica, optimiza los resultados de la derivación y el tiempo quirúrgico total sin reducir los beneficios de la exéresis laparoscópica (AU)

Objectives: Laparoscopic radical cystectomy has been developed after the expansion of laparoscopic radical prostatectomy. This technique makes possible a minimally invasive approach to muscle-invasive bladder cancer with less blood loss and faster postoperative recovery. Methods: From September 2004 to January 2007, 54 laparoscopic radical cystectomies were performed, 48 of them in stage T2, from which 43 (90%) were male and 5 (10%) female patients. Mean age was 64 years (27-88). Lymphadenectomy was carried out by laparoscopic approach in all cases, with a mean of 13 nodes obtained (4-24). Urinary diversion was done through the incision needed to extract the specimen in all cases but one that was completed completely intracorporeally; constructing a Bricker-type ureteroileostomy in 30 (62%) cases, orthotopic neobladder (Vesica Ileale Padovana) in 17 cases (35%), and cutaneous ureterostomy in 1 case (2%). Results: Mean surgical time for the whole procedure was 287 minutes (180-480), 270 minutes for Bricker-type derivation cases and 316 minutes for neobladder cases. Blood transfusion rate was 25%. Mean ileal paralysis was 5 days (2-10) with a mean hospital stay of 13 days (6-34) for Bricker cases and 16 days (8-30) for neobladder cases. Oncological control, after a mean follow-up of 10,8 months (0,4-30), showed a cancer-specific survival of 90% with a mean survival time of 28 months (95% CI 26-30). Global mean survival was 79% with a mean survival of 26 months (95% CI 23-29). Conclusions: Laparoscopic radical cystectomy is a feasible technique that offers some advantages. It allows excision with less blood loss and an easier postoperative period. Randomized studies should demonstrate these advantages to confirm this approach as the technique of choice. Urinary diversion performed through the laparotomy incision, necessary to extract the specimen, optimizes derivation results and whole surgical time without reducing the beneficial effects of the laparoscopic exeresis (AU)

[Pig model in experimental renal transplant surgery]. / El modelo porcino en la cirugía experimental del trasplante renal.

INTRODUCTION AND OBJECTIVES: Living donor laparoscopic renal procurement is becoming a first-line technique unless a show-learning curve. January 2006 we implement an experimental pig-kidney transplant model with the objective of evaluating differences between open and laparosopic surgical techniques as well as giving a training-oportunity to the Residents in these alternatives. MATERIAL AND METHODS: We have completed 25 experiments 7 out of which were performed laparoscopically (28%), 18 with conventional surgerY (72%). Only 44% of the animals have survived until the end of the process. RESULTS: This work evaluates different aspects on the implementation of this activity. Complications of the prothocol are analyzed. We review the literature on this topic. CONCLUSIONS: Experimental Surgery in a porcine model has become in our Hospital a key-issue for Residents Training Program, and easily could be adapted to other Centers.

Schwanoma retroperitoneal benigno, exéresis por laparoscopia / Benigne retroperitoneal schwannoma, laparoscopic ressection

Los Schwanomas son tumores raramente localizados en el retroperitoneo, ya que habitualmente se encuentran en nervios craneales o periféricos. Raramente se diagnostican preoperatoriamente ya que ninguna de las técnicas de imagen es capaz de determinarlos con certeza. La RMN parece la prueba de elección. La exéresis quirúrgica completa es el tratamiento estándar. El caso que presentamos corresponde aun schwanoma retroperitoneal benigno como hallazgo a partir de dolor lumbar, en el describimos por primera vez la resección laparoscópica de este tipo de tumors (AU)

Schwannomas are tumors rarely localized in the retroperitoneum, generally appear in craneal as well as periferic nerves. Seldom cases the diagnosis is preoperatively made just because imaging is very poor in this field. MRI is proven to be the diagnostic method. Radical surgical ressection is standarized treatment. We document a case of a benign retroperitoneal schwannoma where we explain the laparoscopic resection of this kind of tumors for first time (AU)

Angiomiolipomas renales: presentación, tratamiento y resultado de 20 casos / Renal angiomyolipoma: presentation, treatment and results of 20 cases

Introducción: Los angiomiolipomas renales son tumores benignos. Ocasionalmente la ruptura espontánea de los mismos puede poner en peligro la vida de los pacientes. Tanto el tratamiento quirúrgico como la embolización arterial selectiva son tratamientos válidos para dichas lesiones. Objetivos: Analizar los casos de angiomiolipomas renales tratados en nuestro centro, la presentación clínica y el tratamiento indicados en cada uno. Material y método: Se revisan de forma retrospectiva 20 pacientes con angiomiolipomas renales tratados durante el período comprendido entre marzo de 1996 y marzo de 2006. Se describen las características de dichos tumores, el tratamiento recibido y los resultados obtenidos. Resultados: Los pacientes afectados de esclerosis tuberosa (20%) presentaban tumores múltiples y bilaterales, aunque de tamaño similar a los del resto de pacientes. El diagnóstico de síndrome de esclerosis tuberosa fue el único factor asociado a la ruptura espontánea de las lesiones. Cuatro de los 9 pacientes embolizados de urgencia presentaron resangrado (44,4%) y 4 del total de los 16 casos embolizados (25%) sufrieron el síndrome post-embolización, sin hallar ningún factor predictor para ninguna de las dos situaciones. Un 58,4% de los tumores embolizados presentaron reducciones del tamaño inferiores a un tercio de linicial, caracterizándose éstos por ser múltiples, bilaterales y de mayor tamaño que el resto. No se hallaron diferencias significativas en los niveles de creatinina plasmática antes y después de cada tratamiento. Conclusiones: Los angiomiolipomas renales parecen comportarse de forma más agresiva en los pacientes con síndrome de esclerosis tuberosa. No hemos hallado factores predictores de resangrado ni del síndrome post-embolización. Tanto la cirugía como la embolización arterial no parecen comprometer la función renal de los pacientes tratados (AU)

Introduction: Renal angiomyolipoma is a benign tumour, but its spontaneous rupture may become threatening for patient’s live. Both surgery and selective arterial embolization are accepted treatments for this lesion. Objectives: Analyze renal angyolipoma treated in our center, their clinical outcome and treatment purposed in each case. Material and Methods: We retrospectively analyse 20 cases of patients with renal angiomyolipoma treated in our centre from March 1996 to March 2006. We describe tumour characteristics, treatment followed and results obtained. Results: Patients suffering from tuberous sclerosis (20%) showed multiple bilateral tumours, with size similar to the rest of patients. Diagnosis of tuberous sclerosis was the only factor attached to spontaneous rupture of those lesions. Four of 9 emergency embolized patients (44.4%) required from second treatment because of recurrent haemorrhage, and 4 of the 16 embolization episodes (25%) presented post-embolization syndrome, both with no predicting factors attached. Reduction of less than one third of the inicial diameter was observed in 58.4% of embolized tumours, which used to be multiple, bilateral and of size larger to the rest. No significative differences were observed in plasmatic creatinine after and before treatments. Conclusions: Renal angiomyolipoma may behave in an aggressive way in patients with tuberous sclerosis. No predicting factors of recurrent haemorrhage or post-embolization syndrome were observed. Both surgery and arterial embolization have proved not to compromise renal function in treated patients (AU)